Global Governance of Antimicrobial Resistance and Related Infectious Disease Threats

Dear colleagues,

The increasing emergence of antimicrobial resistance (AMR), in addition to the threat of wide-spread epidemics and various infectious disease challenges, pose significant threats to the social, economic, and health security of communities and countries around the world. AMR and the incidence of many infectious diseases can be enabled, accelerated, and allowed to spread by shortcomings in global governance of health security, which is often supported by less-than-ideal institutions, structures, and arrangements. These challenges transcend borders and require multi-sectoral and multi-jurisdictional cooperation, planning, and preparedness to ensure the world is safe from global health threats.

We know that Canadian researchers are studying the nature and effectiveness of global governance arrangements, institutions, and structures across a range of global infectious disease challenges. We also know that these researchers are working to identify strategies for addressing these challenges. To better respond to future threats, this community of scholars could make more significant and timely contributions if they were better connected to one another and better connected to other key players collectively working to prevent AMR and to improve infectious disease preparedness.

To address these challenges, CIHR’s Institute of Infection and Immunity (CIHR-III) and CIHR’s Institute of Population and Public Health (CIHR-IPPH) are pleased to announce that a Catalyst Grant is now available to Canadian researchers to help encourage and support collaborations across the range of social sciences currently studying the arrangements, systems, and institutions working to prevent, detect, and manage AMR and other infectious disease threats. It is our hope that this grant will help to ensure that researchers in Canada are better prepared to study these issues, connected to one another, and capable of contributing to global collaborations and actions. The total amount available for this opportunity is currently $600,000, enough to fund approximately 6 grants of up to $100,000 each for up to 1 year. CIHR-III and CIHR-IPPH have also been leading a conversation with international health research funders to identify opportunities for supporting social science research on infectious disease threats and the application of that knowledge for improved population health. It is our hope that the Catalyst Grant will be the first of additional supports for this important work.

Sincerely,

Dr. Steven Hoffman
Scientific Director, CIHR Institute of Population and Public Health

Dr. Marc Ouellette
Scientific Director, CIHR Institute of Infection and Immunity

Date modified: